Your browser doesn't support javascript.
loading
Nazartinib for treatment-naive EGFR-mutant non-small cell lung cancer: Results of a phase 2, single-arm, open-label study.
Tan, Daniel S W; Kim, Sang-We; Ponce Aix, Santiago; Sequist, Lecia V; Smit, Egbert F; Yang, James C H; Hida, Toyoaki; Toyozawa, Ryo; Felip, Enriqueta; Wolf, Juergen; Grohé, Christian; Leighl, Natasha B; Riely, Gregory; Cui, Xiaoming; Zou, Mike; Ghebremariam, Samson; O'Sullivan-Djentuh, Leslie; Belli, Riccardo; Giovannini, Monica; Kim, Dong-Wan.
Afiliação
  • Tan DSW; National Cancer Centre Singapore, Singapore. Electronic address: daniel.tan.s.w@singhealth.com.sg.
  • Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Ponce Aix S; Hospital Universitario 12 De Octubre, Madrid, Spain.
  • Sequist LV; Massachusetts General Hospital, Boston, MA, USA.
  • Smit EF; Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Yang JCH; National Taiwan University Cancer Center, Taipei, Taiwan.
  • Hida T; Aichi Cancer Center, Nagoya, Japan.
  • Toyozawa R; Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Felip E; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), UVic-UCC, IOB-Quiron, Barcelona, Spain.
  • Wolf J; Department of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany.
  • Grohé C; Evangelische Lungenklinik Berlin, Berlin, Germany.
  • Leighl NB; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Riely G; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
  • Cui X; Novartis Institutes for BioMedical Research, East Hanover, NJ, USA.
  • Zou M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Ghebremariam S; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • O'Sullivan-Djentuh L; Novartis Pharma AG, Basel, Switzerland.
  • Belli R; Novartis Pharma AG, Basel, Switzerland.
  • Giovannini M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Kim DW; Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.
Eur J Cancer ; 172: 276-286, 2022 09.
Article em En | MEDLINE | ID: mdl-35810553
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article